SYNLAB AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.13 EUR | +0.27% |
|
-0.54% | -2.63% |
| Jun. 10 | After cyber attack: British hospitals urgently need blood donations | DP |
| Jun. 04 | Hackers attack laboratory chain Synlab again: 'repercussions' for patients | DP |
| Sales 2024 * | 2.86B 3.07B | Sales 2025 * | 3.02B 3.25B | Capitalization | 2.44B 2.62B |
|---|---|---|---|---|---|
| Net income 2024 * | 81M 87.02M | Net income 2025 * | 67M 71.98M | EV / Sales 2024 * | 1.37 x |
| Net Debt 2024 * | 1.47B 1.58B | Net Debt 2025 * | 1.64B 1.76B | EV / Sales 2025 * | 1.35 x |
| P/E ratio 2024 * |
30
x | P/E ratio 2025 * |
37
x | Employees | 27,000 |
| Yield 2024 * |
1.85% | Yield 2025 * |
1.85% | Free-Float | 14.25% |
More Fundamentals
* Assessed data
More news
Latest transcript on SYNLAB AG
More press releases
More news
| 1 day | +0.18% | ||
| 1 week | -0.36% | ||
| Current month | +0.18% | ||
| 1 month | +8.40% | ||
| 3 months | -0.80% | ||
| 6 months | -3.56% | ||
| Current year | -2.80% |
1 week
10.98
11.24
1 month
10.2011.24
Current year
10.1012.43
1 year
8.0212.43
3 years
6.6825.00
5 years
6.6825.00
10 years
6.6825.00
| Managers | Title | Age | Since |
|---|---|---|---|
Mathieu Floreani
CEO | Chief Executive Officer | 56 | 21-01-25 |
Sami Badarani
DFI | Director of Finance/CFO | 61 | 21-01-25 |
Henrik Andreasen
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Ebsworth
CHM | Chairman | 69 | 21-01-10 |
| Founder | 63 | 97-12-31 | |
Peter Catterall
BRD | Director/Board Member | 56 | 21-01-10 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.29% | 125 M€ | -.--% | - | |
| 0.55% | 17 M€ | -.--% | - | |
| 0.18% | 18 M€ | +7.68% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-12 | 11.12 | +0.18% | 7 742 |
| 24-06-11 | 11.1 | 0.00% | 16,671 |
| 24-06-10 | 11.1 | 0.00% | 70,497 |
| 24-06-07 | 11.1 | -0.18% | 6,908 |
| 24-06-06 | 11.12 | -0.54% | 59,038 |
Delayed Quote Xetra, June 11, 2024 at 11:35 am EDT
More quotes
Synlab AG is a Germany based clinical laboratory and medical diagnostic services provider. The Company is engaged in laboratory services for human and veterinary medicine, as well as environmental analysis.
Calendar
2024-08-07
- Q2 2024 Earnings Call
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
11.1
EUR
Average target price
14.5
EUR
Spread / Average Target
+30.63%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -2.80% | 2.62B | |
| -22.07% | 7.87B | |
| +75.81% | 4.52B | |
| +7.31% | 2.78B | |
| -50.25% | 2B | |
| -18.67% | 1.68B | |
| -19.73% | 1.47B | |
| +18.95% | 1.22B | |
| -44.86% | 1.12B | |
| +22.68% | 993M |
- Stock Market
- Equities
- SYAB Stock
